DGAP-News

MorphoSys to Present at Upcoming Conferences

DGAP-News: MorphoSys AG / Key word(s): Conference MorphoSys to Present at Upcoming Conferences (news with additional features) 11.04.2017 / 14:00 The issuer is solely responsible for the content of this announcement. Planegg/Munich, Germany, April 11, 2017

MorphoSys to Present at Upcoming Conferences

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) will present at the following conferences:

10^th Kempen Life Sciences Conference

Date: April 19, 2017

Venue: Amsterdam, Netherlands

Presenter: Jens Holstein, Chief Financial Officer of MorphoSys AG

UBS Global Healthcare Conference

Date: May 22/23, 2017

Venue: New York, NY, USA

Presenter: Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG

Berenberg European Conference

Date: May 24, 2017

Venue: Tarrytown, NY, USA

Presenter: Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG


A PDF version of the presentation will be provided at www.morphosys.com.

The Annual General Meeting of MorphoSys AG will take place on May 17, 2017 in Munich. A live webcast of the event and all related information are available on www.morphosys.com/agm.

About MorphoSys:

MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other patented technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare.

Together with its pharmaceutical partners, MorphoSys has built a therapeutic pipeline of more than 100 human antibody drug candidates for the treatment of cancer, rheumatoid arthritis, and Alzheimer's disease, to name just a few. With its ongoing commitment to new antibody technology and drug development, MorphoSys is focused on making the healthcare products of tomorrow. MorphoSys is listed on the Frankfurt Stock Exchange under the symbol MOR. For regular updates about MorphoSys, visit http://www.morphosys.com.